Literature DB >> 2249910

HLA and uveitis.

T E Feltkamp1.   

Abstract

The association between HLA-A29 and birdshot chorioretinopathy is the strongest of all associations between HLA and disease. Determination of HLA-A29 is even of diagnostic significance. The association between HLA-B27 and acute anterior uveitis (AAU) is much weaker, but B27 positive AAU may be considered as a distinct clinical entity. B27 positive patients with AAU should be referred to a rheumatologist, because half of these patients have ankylosing spondylitis or Reiter's syndrome. The determination of HLA-Bw51 is of limited but significant diagnostic value for the diagnosis of Behçet's disease. The present article shows how HLA determinations can serve as diagnostic tests. It is explained how the sensitivity and specificity of such tests can be used to calculate the influence of positive or negative results on the probability of the diagnosis. The structure and function of HLA class I molecules is now known to a great extent. This may lead to a better understanding of the pathogenic role of HLA-A29, HLA-B27, HLA-Bw51 and other HLA molecules which are associated with uveitis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2249910     DOI: 10.1007/bf00163552

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  10 in total

1.  Letter: Nomogram for Bayes theorem.

Authors:  T J Fagan
Journal:  N Engl J Med       Date:  1975-07-31       Impact factor: 91.245

Review 2.  Acute anterior uveitis and HLA-B27.

Authors:  P J Derhaag; T E Feltkamp
Journal:  Int Ophthalmol       Date:  1990-01       Impact factor: 2.031

3.  HLA typing in birdshot chorioretinopathy.

Authors:  H A Priem; A Kijlstra; L Noens; G S Baarsma; J J De Laey; J A Oosterhuis
Journal:  Am J Ophthalmol       Date:  1988-02-15       Impact factor: 5.258

4.  Acute anterior uveitis and HLA-B27 subtypes.

Authors:  P J Derhaag; L P de Waal; A Linssen; T E Feltkamp
Journal:  Invest Ophthalmol Vis Sci       Date:  1988-07       Impact factor: 4.799

Review 5.  B27 positive diseases versus B27 negative diseases.

Authors:  A Linssen; T E Feltkamp
Journal:  Ann Rheum Dis       Date:  1988-05       Impact factor: 19.103

6.  Structure of the human class I histocompatibility antigen, HLA-A2.

Authors:  P J Bjorkman; M A Saper; B Samraoui; W S Bennett; J L Strominger; D C Wiley
Journal:  Nature       Date:  1987 Oct 8-14       Impact factor: 49.962

7.  Clinical features of acute anterior uveitis.

Authors:  A Rothova; W G van Veenedaal; A Linssen; E Glasius; A Kijlstra; P T de Jong
Journal:  Am J Ophthalmol       Date:  1987-02-15       Impact factor: 5.258

8.  The use of HLA-B27 as a diagnostic and prognostic aid in acute anterior uveitis (AAU) in The Netherlands.

Authors:  A Linssen; A J Dekker-Saeys; P F Dijkstra; A Rothova; P J Kruit; M Bakker; A Kijlstra; T E Feltkamp
Journal:  Doc Ophthalmol       Date:  1986       Impact factor: 2.379

9.  A familial study of the inheritance of HLA-B27-positive acute anterior uveitis.

Authors:  P J Derhaag; A Linssen; N Broekema; L P de Waal; T E Feltkamp
Journal:  Am J Ophthalmol       Date:  1988-06-15       Impact factor: 5.258

10.  HLA-B27+ acute anterior uveitis and other antigens of the major histocompatibility complex.

Authors:  P J Derhaag; A R van der Horst; L P de Waal; T E Feltkamp
Journal:  Invest Ophthalmol Vis Sci       Date:  1989-10       Impact factor: 4.799

  10 in total
  3 in total

1.  Anti-mitochondrial antibody IgG subclass distribution and affinity in primary biliary cirrhosis.

Authors:  L Zhang; A P Weetman; D R Jayne; I Turner; S J Yeaman; M F Bassendine; D B Oliveira
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

2.  Polymorphism in clinical immunology - From HLA typing to immunogenetic profiling.

Authors:  Ping Jin; Ena Wang
Journal:  J Transl Med       Date:  2003-11-18       Impact factor: 5.531

3.  Seroprevalence against Rickettsia and Borrelia Species in Patients with Uveitis: A Prospective Survey.

Authors:  Kim B Madsen; Katarina Wallménius; Åke Fridman; Carl Påhlson; Kenneth Nilsson
Journal:  J Ophthalmol       Date:  2017-11-26       Impact factor: 1.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.